Alzheimer's disease & dementia

Another angle on Alzheimer's: CSF, proteomics, and metabolic enzymes

Currently there are no objective, easily assessed diagnostic markers for Alzheimer's disease, and no good therapeutic options. Taking an agnostic approach, proteomics expert Hanno Steen, Ph.D., and neurobiologist Judith Steen, ...

Neuroscience

A key biological pathway for multiple sclerosis uncovered

Cross-talk between brain cells and peripheral immune cells can modulate the progression of multiple sclerosis (MS), Mount Sinai researchers have discovered. Their findings reveal a previously unknown way in which the brain ...

Neuroscience

Language impairment in autism associated with gray matter volume

Researchers from Russia and the U.S. have found language impairment in children with Autism Spectrum Disorder (ASD) to be associated with a lower volume of gray matter and greater gyrification in the temporal and frontal ...

Alzheimer's disease & dementia

A more convenient and accessible way to diagnose Alzheimer's disease?

Despite extensive research and encouraging findings, Alzheimer's disease (AD) remains difficult to diagnose based on signs and symptoms alone. But what if one day, a blood sample during an annual check-up could be used to ...

Neuroscience

Potential 'game-changer' in diagnosing Parkinson's disease

A certain protein builds up in the brains of most Parkinson's patients, a study confirmed on Thursday using a new technique hailed as a potential "game-changer" that could point towards a way to test for the debilitating ...

page 7 from 36